The role of pharmaceutical agents in appetite stimulation in patients with end-stage renal disease
- 31 July 1996
- journal article
- review article
- Published by Elsevier in Journal of Renal Nutrition
- Vol. 6 (3) , 127-133
- https://doi.org/10.1016/s1051-2276(96)90050-3
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- How Important Is the Problem of Malnutrition in Chronic Dialysis Patients?Seminars in Dialysis, 2007
- Management of hypoalbuminemia: A challenge for the health care teamJournal of Renal Nutrition, 1996
- Clinical approaches to nutritional support in cancerCurrent Opinion in Oncology, 1993
- Treatment of Anorexia With Megestrol AcetateNutrition in Clinical Practice, 1993
- Nutrition in Advanced Cancer: Anorexia as an Outcome Variable and Target of TherapyJournal of Parenteral and Enteral Nutrition, 1992
- A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancerCancer, 1990
- A controlled trial of cyproheptadine in cancer patients with anorexia and/or cachexiaCancer, 1990
- EFFECT OF HYDRAZINE SULPHATE ON WHOLE-BODY PROTEIN BREAKDOWN MEASURED BY 14C-LYSINE METABOLISM IN LUNG CANCER PATIENTSThe Lancet, 1987
- Cardiovascular and Metabolic Considerations in Prolonged Cannabinoid Administration in ManThe Journal of Clinical Pharmacology, 1981
- Antiemetics in Patients Receiving Chemotherapy for CancerNew England Journal of Medicine, 1980